Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 31 citing articles:

CD147-spike protein interaction in COVID-19: Get the ball rolling with a novel receptor and therapeutic target
Tapan Behl, Ishnoor Kaur, Lotfi Aleya, et al.
The Science of The Total Environment (2021) Vol. 808, pp. 152072-152072
Open Access | Times Cited: 97
Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2
Kaifu Gao, Rui Wang, Jiahui Chen, et al.
Chemical Reviews (2022) Vol. 122, Iss. 13, pp. 11287-11368
Open Access | Times Cited: 58
A contemporary review on the important role of in silico approaches for managing different aspects of COVID-19 crisis
Mohammad Moradi, Reza Golmohammadi, Ali Najafi, et al.
Informatics in Medicine Unlocked (2022) Vol. 28, pp. 100862-100862
Open Access | Times Cited: 55
COVID-19 and atrial fibrillation: Intercepting lines
Maria Donniacuo, Antonella De Angelis, Concetta Rafaniello, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 24
Drug repurposing for SARS-CoV-2 main protease: Molecular docking and molecular dynamics investigations
Samia E. Omer, Tawasol M. Ibrahim, Omer A. Krar, et al.
Biochemistry and Biophysics Reports (2022) Vol. 29, pp. 101225-101225
Open Access | Times Cited: 32
Cheminformatics Strategies Unlock Marburg Virus VP35 Inhibitors from Natural Compound Library
Isra Alsaady, Leena H. Bajrai, Thamir A. Alandijany, et al.
Viruses (2023) Vol. 15, Iss. 8, pp. 1739-1739
Open Access | Times Cited: 15
Repurposing clinically available drugs and therapies for pathogenic targets to combat SARS‐CoV‐2
Yiying Xue, Husheng Mei, Yisa Chen, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 11
Novel Drug Design for Treatment of COVID-19: A Systematic Review of Preclinical Studies
Sarah Mousavi, Shima Zare, Mahmoud Mirzaei, et al.
Canadian Journal of Infectious Diseases and Medical Microbiology (2022) Vol. 2022, pp. 1-70
Open Access | Times Cited: 18
Emerging Strategies and Progress in the Medical Management of Marburg Virus Disease
Sanctus Musafiri, Emmanuel Edwar Siddig, John Baptist Nkuranga, et al.
Pathogens (2025) Vol. 14, Iss. 4, pp. 322-322
Open Access
Development of a novel human CD147 knock-in NSG mouse model to test SARS-CoV-2 viral infection
Saiaditya Badeti, Qingkui Jiang, Alireza Naghizadeh, et al.
Cell & Bioscience (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 11
Scope of repurposed drugs against the potential targets of the latest variants of SARS-CoV-2
Vidya Niranjan, Anagha S Setlur, Chandrashekar Karunakaran, et al.
Structural Chemistry (2022) Vol. 33, Iss. 5, pp. 1585-1608
Open Access | Times Cited: 11
Rational design of an anti-cancer peptide inhibiting CD147 / Cyp A interaction
Zahra Maani, Safar Farajnia, Leila Rahbarnia, et al.
Journal of Molecular Structure (2022) Vol. 1272, pp. 134160-134160
Open Access | Times Cited: 11
Angiotensin-Converting Enzyme 2-Based Biosensing Modalities and Devices for Coronavirus Detection
Ijaz Gul, Shiyao Zhai, Xiaoyun Zhong, et al.
Biosensors (2022) Vol. 12, Iss. 11, pp. 984-984
Open Access | Times Cited: 11
Enzymes in the time of COVID‐19: An overview about the effects in the human body, enzyme market, and perspectives for new drugs
Luana Xavier Soares Gomes Moura Fé, Eliane Pereira Cipolatti, Martina C. C. Pinto, et al.
Medicinal Research Reviews (2022) Vol. 42, Iss. 6, pp. 2126-2167
Open Access | Times Cited: 10
Intrinsic Dynamics of the ClpXP Proteolytic Machine Using Elastic Network Models
Lenin González-Paz, Carla Lossada, María Laura Hurtado-León, et al.
ACS Omega (2023) Vol. 8, Iss. 8, pp. 7302-7318
Open Access | Times Cited: 5
Predicting for anti-(mutant) SARS-CoV-2 and anti-inflammation compounds of Lianhua Qingwen Capsules in treating COVID-19
Hong Liang, Min He, Shaoping Li, et al.
Chinese Medicine (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 8
Analysis of Biomolecular Interaction Process Based on SPR Imaging Method in Microfluidic Chips
Honggang Wang, Huixiang Wang, Zhen Tian, et al.
Plasmonics (2021) Vol. 17, Iss. 2, pp. 621-631
Closed Access | Times Cited: 8
Computational Approach to Combat COVID-19 Infection: Emerging Tools for Accelerating Drug Research
Biswa Mohan Sahoo, Subrat Kumar Bhattamisra, Sarita Das, et al.
Current Drug Discovery Technologies (2022) Vol. 19, Iss. 3
Closed Access | Times Cited: 5
Interaction of the new inhibitor paxlovid (PF-07321332) and ivermectin with the monomer of the main protease SARS-CoV-2: A volumetric study based on molecular dynamics, elastic networks, classical thermodynamics and SPT
Ysaías J. Alvarado, Yosmari Olivarez, Carla Lossada, et al.
Computational Biology and Chemistry (2022) Vol. 99, pp. 107692-107692
Open Access | Times Cited: 5
Identification of a New Drug Binding Site in the RNA-Dependent-RNA-Polymerase (RdRp) Domain
Aparna S. Gana, James N. Baraniuk
BioMedInformatics (2023) Vol. 3, Iss. 4, pp. 885-907
Open Access | Times Cited: 2
Angiotensin-converting enzyme 2-based biosensing modalities and devices for coronavirus detection
Ijaz Gul, Shiyao Zhai, Xiaoyun Zhong, et al.
(2022)
Open Access | Times Cited: 3
Computational Modeling in the Development of Antiviral Agents
Priyank Purohit, Pobitra Borah, Sangeeta Hazarika, et al.
Challenges and advances in computational chemistry and physics (2023), pp. 109-136
Closed Access | Times Cited: 1
In silico analysis of balsaminol as anti-viral agents targeting SARS-CoV-2 main protease, spike receptor binding domain and papain-like protease receptors
Daniel Danladi Gaiya, Aliyu Muhammad, Joy Sim Musa, et al.
In Silico Pharmacology (2024) Vol. 12, Iss. 2
Open Access
Molecular Docking and Molecular Dynamics Simulations of Molnupiravir Against Covid-19
Tugce Sinem Oktemer, Z. Çiçek Önem, Sefa Çeli̇k, et al.
Muş Alparslan Üniversitesi Fen Bilimleri Dergisi (2024)
Open Access
Macromolecular interaction mechanism of the bacteriocin EntDD14 with the receptor binding domain (RBD) for the inhibition of SARS-CoV-2 and the JN.1 variant: Biomedical study based on elastic networks, stochastic Markov models, and macromolecular volumetric analysis
Luis Moncayo-Molina, María Erlinda Aguaiza Pichazaca, José Suárez Padilla, et al.
Biophysical Chemistry (2024) Vol. 318, pp. 107388-107388
Closed Access
Page 1 - Next Page

Scroll to top